Postoperative circulating tumor DNA as markers of recurrence risk in stages II to III colorectal cancer

Postoperative circulating tumor DNA as markers of recurrence risk in stages II to III colorectal cancer

Abstract Background Precise methods for postoperative risk stratification to guide the administration of adjuvant chemotherapy (ACT) in localized colorectal cancer (CRC) are still lacking. Here, we conducted a prospective, observational, and multicenter study to investigate the utility of circulatin...

Full description

Bibliographic Details
Main Authors: Gong Chen, Junjie Peng, Qian Xiao, Hao-Xiang Wu, Xiaojun Wu, Fulong Wang, Liren Li, Peirong Ding, Qi Zhao, Yaqi Li, Da Wang, Yang Shao, Hua Bao, Zhizhong Pan, Ke-Feng Ding, Sanjun Cai, Feng Wang, Rui-Hua Xu
Format: Article
Language:English
Published: BMC 2021-05-01
Series:Journal of Hematology & Oncology
Subjects:
Stage II/III colorectal cancer
Minimal residual disease
Circulating tumor DNA
Recurrence risk
Adjuvant chemotherapy
Online Access:https://doi.org/10.1186/s13045-021-01089-z

Internet

https://doi.org/10.1186/s13045-021-01089-z

Similar Items